On the public citation graph

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

https://doi.org/10.1126/science.aan3706
0 signed · 5636 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2016.4059openalex-snapshot
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
inferredcites →https://doi.org/10.1016/j.cell.2017.01.022openalex-snapshot
Mining the Human Gut Microbiota for Immunomodulatory Organisms
inferredcites →https://doi.org/10.1016/j.ejca.2008.10.026openalex-snapshot
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
inferredcites →https://doi.org/10.1016/j.immuni.2016.09.009openalex-snapshot
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects
inferredcites →https://doi.org/10.1016/j.ygeno.2013.07.011openalex-snapshot
AlienTrimmer: A tool to quickly and accurately trim off multiple short contaminant sequences from high-throughput sequencing reads
inferredcites →https://doi.org/10.1038/nature12480openalex-snapshot
Dietary intervention impact on gut microbial gene richness
inferredcites →https://doi.org/10.1038/nature12506openalex-snapshot
Richness of human gut microbiome correlates with metabolic markers
inferredcites →https://doi.org/10.1038/nature14404openalex-snapshot
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
inferredcites →https://doi.org/10.1038/nature21349openalex-snapshot
Elements of cancer immunity and the cancer–immune set point
inferredcites →https://doi.org/10.1038/nbt.2939openalex-snapshot
Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes
inferredcites →https://doi.org/10.1038/nbt.2942openalex-snapshot
An integrated catalog of reference genes in the human gut microbiome
inferredcites →https://doi.org/10.1038/ncomms10501openalex-snapshot
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
inferredcites →https://doi.org/10.1038/ng.3677openalex-snapshot
Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy
inferredcites →https://doi.org/10.1038/nmeth.1923openalex-snapshot
Fast gapped-read alignment with Bowtie 2
inferredcites →https://doi.org/10.1038/nrclinonc.2015.209openalex-snapshot
Combination cancer immunotherapies tailored to the tumour microenvironment
inferredcites →https://doi.org/10.1038/nri3191openalex-snapshot
Adoptive immunotherapy for cancer: harnessing the T cell response
inferredcites →https://doi.org/10.1053/j.seminoncol.2015.05.003openalex-snapshot
Cancer and the Immune System: Basic Concepts and Targets for Intervention
inferredcites →https://doi.org/10.1056/nejmoa1104621openalex-snapshot
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
inferredcites →https://doi.org/10.1056/nejmoa1200690openalex-snapshot
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
inferredcites →https://doi.org/10.1056/nejmoa1411087openalex-snapshot
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
inferredcites →https://doi.org/10.1056/nejmoa1507643openalex-snapshot
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1056/nejmoa1510665openalex-snapshot
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
inferredcites →https://doi.org/10.1056/nejmoa1613493openalex-snapshot
First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1126/science.1240527openalex-snapshot
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
inferredcites →https://doi.org/10.1126/science.1240537openalex-snapshot
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
inferredcites →https://doi.org/10.1126/science.aaa1348openalex-snapshot
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
inferredcites →https://doi.org/10.1126/science.aaa4971openalex-snapshot
Neoantigens in cancer immunotherapy
inferredcites →https://doi.org/10.1126/science.aac4255openalex-snapshot
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
inferredcites →https://doi.org/10.1126/science.aad1329openalex-snapshot
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
inferredcites →https://doi.org/10.1126/science.aad9358openalex-snapshot
Antibiotic use and its consequences for the normal microbiome
inferredcites →https://doi.org/10.1128/aem.01477-07openalex-snapshot
Intestinal Integrity and Akkermansia muciniphila , a Mucin-Degrading Member of the Intestinal Microbiota Present in Infants, Adults, and the Elderly
inferredcites →https://doi.org/10.1128/aem.65.11.4799-4807.1999openalex-snapshot
Direct Analysis of Genes Encoding 16S rRNA from Complex Communities Reveals Many Novel Molecular Species within the Human Gut
inferredcites →https://doi.org/10.1136/gutjnl-2015-310861openalex-snapshot
Proton pump inhibitors alter the composition of the gut microbiota
inferredcites →https://doi.org/10.1158/0008-5472.can-15-3142openalex-snapshot
Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy
inferredcites →https://doi.org/10.1200/jco.2016.70.3348openalex-snapshot
Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3199993openalex-extracted
The Gut and Cervical Microbiome Promote Immune Activation and Response to Chemoradiation in Cervical Cancer
inferred← citeshttps://doi.org/10.2139/ssrn.3202936openalex-extracted
Lipopolysaccharide Potentiates PD-1 Targeted Therapies During Chronic Viral Infection
inferred← citeshttps://doi.org/10.2139/ssrn.3346978openalex-extracted
In Situ Transfection of Interleukin 12 Plasmid Enhances Anti-PD-1 Immune Response in Patients with Immunologically Quiescent Melanoma
inferred← citeshttps://doi.org/10.2139/ssrn.3982290openalex-extracted
Impact of Antacid Exposure on Efficacy of Patients Treated with Immune Checkpoint Inhibitors in: A Study Based on 4,818 Individuals
inferred← citeshttps://doi.org/10.2139/ssrn.4119252openalex-extracted
Cascades Catalyzed Lactic Acid Depletion Coordinated with Photothermal Therapy for Enhanced Cancer Immunotherapy
inferred← citeshttps://doi.org/10.2139/ssrn.4494355openalex-extracted
inferred← citeshttps://doi.org/10.2139/ssrn.4664812openalex-extracted
Effects of Achyranthes Bidentata Polysaccharide on Gut Microbiota and Metabolites in Lewis Lung Cancer Mice
inferred← citeshttps://doi.org/10.2139/ssrn.4681862openalex-extracted
The Distribution Characteristics and Dynamic Changes of Gut Microbiota Indicates the Efficacy of Immunotherapy in Advanced EGFR-Mutated Non-Small Cell Lung Cancer
inferred← citeshttps://doi.org/10.2139/ssrn.4792764openalex-extracted
Dysbiosis of Fecal Microbiota in Chinese Advanced Non-Small-Cell Lung Cancer Patients and its Role in Response to Immunotherapy
inferred← citeshttps://doi.org/10.2139/ssrn.4795887openalex-extracted
Cinnamic Acid Improves Skeletal Muscle Hypertrophy and Metabolism Through Activation of Gpr109a/Pka Pathway
inferred← citeshttps://doi.org/10.2139/ssrn.4802669openalex-extracted
Lactobacillus Paracasei JN-8 Produces Genistein and Elicits Anti-Tumor Capacity
inferred← citeshttps://doi.org/10.1001/jama.2018.12179openalex-snapshot
Antibiotics for Sepsis—Finding the Equilibrium
inferred← citeshttps://doi.org/10.1001/jama.2025.2191openalex-snapshot
The Microbiome and Cancer
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2020.2895openalex-snapshot
Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2023.4254openalex-snapshot
Association of Antibiotic Receipt With Survival Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Receiving Chemotherapy
inferred← citeshttps://doi.org/10.1001/jamaoncol.2019.0518openalex-snapshot
Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer—Beyond the Misdiagnosis
inferred← citeshttps://doi.org/10.1001/jamaoncol.2019.6859openalex-snapshot
Antibiotic Treatment and Immune Checkpoint Inhibitor Therapy in Patients With Cancer
inferred← citeshttps://doi.org/10.1001/jamaoncol.2019.6865openalex-snapshot
Antibiotic Treatment and Immune Checkpoint Inhibitor Therapy in Patients With Cancer
inferred← citeshttps://doi.org/10.1001/jamaoncol.2021.6619openalex-snapshot
Antibiotic Prophylaxis of Surgical Site Infections—A Double-edged Sword for Oncology Patients?
inferred← citeshttps://doi.org/10.1001/jamaoncol.2022.0494openalex-snapshot
The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm
inferred← citeshttps://doi.org/10.1001/jamaoncol.2022.2810openalex-snapshot
Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China
inferred← citeshttps://doi.org/10.1002/1545-5017.70384openalex-snapshot
Intestinal Low‐Dose Radiation to Overcome PD‐1 Resistance in Pediatric Relapsed/Refractory Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.1002/1878-0261.13062openalex-snapshot
Integrative analysis of gut microbiome and host transcriptomes reveals associations between treatment outcomes and immunotherapy‐induced colitis
inferred← citeshttps://doi.org/10.1002/1878-0261.13760openalex-snapshot
Gut microbiota diversity is prognostic and associated with benefit from chemo‐immunotherapy in metastatic triple‐negative breast cancer
inferred← citeshttps://doi.org/10.1002/1878-0261.70326openalex-snapshot
Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm068.pub2openalex-snapshot
Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/9781119282549.ch1openalex-snapshot
Resistance to Aminoglycosides
inferred← citeshttps://doi.org/10.1002/9781119487845.ch35openalex-snapshot
Statistical and Computational Methods in Microbiome and Metagenomics
inferred← citeshttps://doi.org/10.1002/9781119535331.ch5openalex-snapshot
Orthotopic Mouse Models of Colorectal Cancer and Imaging Techniques
inferred← citeshttps://doi.org/10.1002/9781119535331.ch7openalex-snapshot
Humanized Mouse Models for Cancer Immunotherapy: A Focus on Human PBMC and HSPC Reconstitution
inferred← citeshttps://doi.org/10.1002/9781119535331.cintroopenalex-snapshot
Introduction
inferred← citeshttps://doi.org/10.1002/9781119600206.ch143openalex-snapshot
Structure and function of the human microbiome: implications for health and disease
inferred← citeshttps://doi.org/10.1002/9781119660699.ch26openalex-snapshot
Drug–Drug Interactions and Drug–Dietary Chemical Interactions
inferred← citeshttps://doi.org/10.1002/9781119819950.ch30openalex-snapshot
Targeting NF ‐κB in Oncology, an Untapped Therapeutic Potential
inferred← citeshttps://doi.org/10.1002/9781119876007.ch121openalex-snapshot
Microbiome of Pancreatic Cancer
inferred← citeshttps://doi.org/10.1002/9781683670438.mcm0017openalex-snapshot
The Human Microbiome
inferred← citeshttps://doi.org/10.1002/9781683674597.ch7openalex-snapshot
Characterization of the Human Microbiome in Health and Disease
inferred← citeshttps://doi.org/10.1002/adbi.202300528openalex-snapshot
The Function of the Immune System, Beyond Strategies Based on Cell‐Autonomous Mechanisms, Determines Cancer Development: Immune Response and Cancer Development
inferred← citeshttps://doi.org/10.1002/adfm.202000532openalex-snapshot
Inducing Endoplasmic Reticulum Stress to Expose Immunogens: A DNA Tetrahedron Nanoregulator for Enhanced Immunotherapy
inferred← citeshttps://doi.org/10.1002/adfm.202301659openalex-snapshot
Monitoring Melanoma Responses to STING Agonism and Focused Ultrasound Thermal Ablation Using Microneedles and Ultrasensitive Single Molecule Arrays
inferred← citeshttps://doi.org/10.1002/adhm.202401076openalex-snapshot
Recent Advances in Bacterium‐Based Therapeutic Modalities for Melanoma Treatment
inferred← citeshttps://doi.org/10.1002/adhm.202401538openalex-snapshot
The Rational Engineered Bacteria Based Biohybrid Living System for Tumor Therapy
inferred← citeshttps://doi.org/10.1002/adhm.202503198openalex-snapshot
Harnessing Next‐Generation 3D Cancer Models to Elucidate Tumor‐Microbiome Crosstalk
inferred← citeshttps://doi.org/10.1002/adma.201805007openalex-snapshot
Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver Metastasis
inferred← citeshttps://doi.org/10.1002/adma.201904156openalex-snapshot
Nanomedicine‐Based Immunotherapy for the Treatment of Cancer Metastasis
inferred← citeshttps://doi.org/10.1002/adma.202004529openalex-snapshot
Prebiotics‐Encapsulated Probiotic Spores Regulate Gut Microbiota and Suppress Colon Cancer
inferred← citeshttps://doi.org/10.1002/adma.202006104openalex-snapshot
The Microbiome Meets Nanotechnology: Opportunities and Challenges in Developing New Diagnostic Devices
inferred← citeshttps://doi.org/10.1002/adma.202205299openalex-snapshot
Oral Supramolecular Adsorbent for Preventing Chemo‐Induced Gastrointestinal Mucositis and Microbial Dysbiosis and for Enhancing Chemoimmunotherapy
inferred← citeshttps://doi.org/10.1002/adma.202304257openalex-snapshot
Engineering Clinically Relevant Probiotics with Switchable “Nano‐Promoter” and “Nano‐Effector” for Precision Tumor Therapy
inferred← citeshttps://doi.org/10.1002/adma.202306281openalex-snapshot
Antibacterial Fusobacterium nucleatum ‐Mimicking Nanomedicine to Selectively Eliminate Tumor‐Colonized Bacteria and Enhance Immunotherapy Against Colorectal Cancer
inferred← citeshttps://doi.org/10.1002/adts.70488openalex-snapshot
Experimental and Computational Investigation of Probiotic‐Induced Tumor–Immune Dynamics in a 4T1 Murine Breast Cancer Model
inferred← citeshttps://doi.org/10.1002/advs.201801039openalex-snapshot
Engineering Precision Medicine
inferred← citeshttps://doi.org/10.1002/advs.201900721openalex-snapshot
Circulating DNA‐Based Sequencing Guided Anlotinib Therapy in Non‐Small Cell Lung Cancer
inferred← citeshttps://doi.org/10.1002/advs.202101672openalex-snapshot
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
inferred← citeshttps://doi.org/10.1002/advs.202102952openalex-snapshot
Effects of Docetaxel Injection and Docetaxel Micelles on the Intestinal Barrier and Intestinal Microbiota
inferred← citeshttps://doi.org/10.1002/advs.202205563openalex-snapshot
Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer
inferred← citeshttps://doi.org/10.1002/advs.202304781openalex-snapshot
Low‐Dose Chemotherapy Preferentially Shapes the Ileal Microbiome and Augments the Response to Immune Checkpoint Blockade by Activating AIM2 Inflammasome in Ileal Epithelial Cells
inferred← citeshttps://doi.org/10.1002/advs.202310065openalex-snapshot
Urolithin A Hijacks ERK1/2‐ULK1 Cascade to Improve CD8+ T Cell Fitness for Antitumor Immunity
inferred← citeshttps://doi.org/10.1002/advs.202400458openalex-snapshot
Wise Roles and Future Visionary Endeavors of Current Emperor: Advancing Dynamic Methods for Longitudinal Microbiome Meta‐Omics Data in Personalized and Precision Medicine
inferred← citeshttps://doi.org/10.1002/advs.202403075openalex-snapshot
Biomimetic Supramolecular Assembly with IGF‐1C Delivery Ameliorates Inflammatory Bowel Disease (IBD) by Restoring Intestinal Barrier Integrity
inferred← citeshttps://doi.org/10.1002/advs.202403393openalex-snapshot
An Explainable Graph Neural Framework to Identify Cancer‐Associated Intratumoral Microbial Communities
inferred← citeshttps://doi.org/10.1002/advs.202508692openalex-snapshot
Insights into the Mechanisms of Immune‐Checkpoint Inhibitors Gained from Spatiotemporal Dynamics of the Tumor Microenvironment
inferred← citeshttps://doi.org/10.1002/advs.202511887openalex-snapshot
Elemene Augments the Effects of Anti‐PD‐1 Immunotherapy on Hepatocellular Carcinoma by Regulating the miR‐130a‐5p/SPP/MHC‐I Axis
inferred← citeshttps://doi.org/10.1002/advs.202519942openalex-snapshot
Icariin Enhances the Enzymatic Activity of N‐acetylgalactosaminidase to Augment Akkermansia Abundance in Gut Microbiota for Improved PD‐1 Blockade Efficacy in Tumor Suppression
inferred← citeshttps://doi.org/10.1002/agm2.12292openalex-snapshot
Gut microbes as medical signature for the effectiveness of immunotherapy in patients with advanced non‐small cell lung cancer
inferred← citeshttps://doi.org/10.1002/ags3.12710openalex-snapshot
Recent progress in the treatment for unresectable biliary tract cancer
inferred← citeshttps://doi.org/10.1002/ana.26084openalex-snapshot
Gut Microbiome in Progressive Multiple Sclerosis
inferred← citeshttps://doi.org/10.1002/anbr.202300144openalex-snapshot
Memory Effect of Bacteria‐Killing Properties of Piezo‐Catalysts Nanomaterials through Defect Engineering
inferred← citeshttps://doi.org/10.1002/ange.202002780openalex-snapshot
Improving Cancer Immunotherapy Outcomes Using Biomaterials
inferred← citeshttps://doi.org/10.1002/anie.202002780openalex-snapshot
Improving Cancer Immunotherapy Outcomes Using Biomaterials
inferred← citeshttps://doi.org/10.1002/art.41166openalex-snapshot
Bugs, Drugs, and Shrugs
inferred← citeshttps://doi.org/10.1002/art.41622openalex-snapshot
The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New‐Onset Rheumatoid Arthritis
inferred← citeshttps://doi.org/10.1002/bco2.118openalex-snapshot
Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma
inferred← citeshttps://doi.org/10.1002/bies.201800050openalex-snapshot
Understanding Immune Tolerance of Cancer: Re‐Purposing Insights from Fetal Allografts and Microbes
inferred← citeshttps://doi.org/10.1002/bies.201800178openalex-snapshot
Have Causal Claims About the Gut Microbiome Been Over‐Hyped?
inferred← citeshttps://doi.org/10.1002/bies.202000024openalex-snapshot
Why the Outcome of Anti‐Tumor Immune Responses is Heterogeneous: A Novel Idea in the Context of Immunological Heterogeneity in Cancers
inferred← citeshttps://doi.org/10.1002/bies.202100252openalex-snapshot
Cancer's second genome: Microbial cancer diagnostics and redefining clonal evolution as a multispecies process
inferred← citeshttps://doi.org/10.1002/biof.70077openalex-snapshot
Gut Microbiome Strategies for Enhancing ICI Delivery Across the BBB in Glioblastoma
inferred← citeshttps://doi.org/10.1002/bjs.11204openalex-snapshot
Mechanisms of immunogenicity in colorectal cancer
inferred← citeshttps://doi.org/10.1002/bmm2.70130openalex-snapshot
From pathogen to “living drug factory” innovative strategies and clinical translation of bacteria as programmable intelligent vectors for cancer therapy
inferred← citeshttps://doi.org/10.1002/btm2.10728openalex-snapshot
Fecal microbiota transplantation for the treatment of intestinal and extra‐intestinal diseases: Mechanism basis, clinical application, and potential prospect
inferred← citeshttps://doi.org/10.1002/cac2.12178openalex-snapshot
Advancing to the era of cancer immunotherapy
inferred← citeshttps://doi.org/10.1002/cac2.12182openalex-snapshot
Metabolic regulation in the immune response to cancer
inferred← citeshttps://doi.org/10.1002/cac2.12200openalex-snapshot
Harness the functions of gut microbiome in tumorigenesis for cancer treatment
inferred← citeshttps://doi.org/10.1002/cam4.1722openalex-snapshot
Checkpoint blockade‐based immunotherapy in the context of tumor microenvironment: Opportunities and challenges
inferred← citeshttps://doi.org/10.1002/cam4.3346openalex-snapshot
Intestinal microbiota regulates anti‐tumor effect of disulfiram combined with Cu2+ in a mice model
inferred← citeshttps://doi.org/10.1002/cam4.3410openalex-snapshot
Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker
inferred← citeshttps://doi.org/10.1002/cam4.3569openalex-snapshot
Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma
inferred← citeshttps://doi.org/10.1002/cam4.3694openalex-snapshot
Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors
inferred← citeshttps://doi.org/10.1002/cam4.4190openalex-snapshot
PD‐1/PD‐L1 inhibitors‐based treatment for advanced renal cell carcinoma: Mechanisms affecting efficacy and combination therapies
inferred← citeshttps://doi.org/10.1002/cam4.4799openalex-snapshot
Bacteria in cancer therapy: A new generation of weapons
inferred← citeshttps://doi.org/10.1002/cam4.4994openalex-snapshot
Impact of probiotics use on clinical outcomes of immune checkpoint inhibitors therapy in cancer patients
inferred← citeshttps://doi.org/10.1002/cam4.5312openalex-snapshot
Bifidobacterium breve predicts the efficacy of anti‐PD ‐1 immunotherapy combined with chemotherapy in Chinese NSCLC patients
inferred← citeshttps://doi.org/10.1002/cam4.6298openalex-snapshot
Potential role of intratumor bacteria outside the gastrointestinal tract: More than passengers
inferred← citeshttps://doi.org/10.1002/cam4.6313openalex-snapshot
Association of probiotic use with nivolumab effectiveness against various cancers: A multicenter retrospective cohort study
inferred← citeshttps://doi.org/10.1002/cam4.6416openalex-snapshot
Effect of butyrate‐producing enterobacteria on advanced hepatocellular carcinoma treatment with atezolizumab and bevacizumab
inferred← citeshttps://doi.org/10.1002/cam4.6534openalex-snapshot
Deficiency of SR‐B1 reduced the tumor load of colitis‐induced or APCmin /+‐induced colorectal cancer
inferred← citeshttps://doi.org/10.1002/cam4.70143openalex-snapshot
Inosine enhances the efficacy of immune‐checkpoint inhibitors in advanced solid tumors: A randomized, controlled, Phase 2 study
inferred← citeshttps://doi.org/10.1002/cam4.70703openalex-snapshot
The Kynurenine Pathway and Indole Pathway in Tryptophan Metabolism Influence Tumor Progression
inferred← citeshttps://doi.org/10.1002/cam4.71738openalex-snapshot
Influence of Gut Microbiota on Response to Immune Check Point Inhibitors in MASLD Patients With HCC : Unraveling the Connection
inferred← citeshttps://doi.org/10.1002/cam4.72061openalex-snapshot
Harnessing Gut Microbiota to Enhance Immunotherapy in NSCLC : From Mechanisms to Translational Applications
inferred← citeshttps://doi.org/10.1002/cam4.72335openalex-snapshot
Targeting the Tumor Microenvironment Network to Overcome Immunotherapy Resistance in Non‐Small Cell Lung Cancer: Mechanisms to Clinical Translation
inferred← citeshttps://doi.org/10.1002/cam4.7418openalex-snapshot
Lymphocyte activation markers predict the therapeutic response to immune checkpoint inhibitors: A case–control study
inferred← citeshttps://doi.org/10.1002/cbf.70196openalex-snapshot
Comprehensive Overview of Therapeutic Strategies in Colon Cancer: Chemotherapy, Targeted Therapy, and Immunotherapy
inferred← citeshttps://doi.org/10.1002/cncr.33270openalex-snapshot
Immune‐related adverse events of a PD‐L1 inhibitor plus chemotherapy versus a PD‐L1 inhibitor alone in first‐line treatment for advanced non–small cell lung cancer: A meta‐analysis of randomized control trials
inferred← citeshttps://doi.org/10.1002/cncr.33891openalex-snapshot
Altering the microbiome for immunotherapy‐resistant urological tumors—An intriguing but still early concept
inferred← citeshttps://doi.org/10.1002/cncr.33893openalex-snapshot
Fecal microbiota transplantation for immunotherapy‐resistant urological tumors: Is it time? An update of the recent literature
inferred← citeshttps://doi.org/10.1002/cncr.34273openalex-snapshot
Preoperative therapy for pancreatic adenocarcinoma—precision beyond anatomy
inferred← citeshttps://doi.org/10.1002/cncr.34748openalex-snapshot
Analysis of the fecal metagenome in long‐term survivors of pancreas cancer
inferred← citeshttps://doi.org/10.1002/cnr2.1752openalex-snapshot
Maternal obesity and resistance to breast cancer treatments among offspring: Link to gut dysbiosis
inferred← citeshttps://doi.org/10.1002/cnr2.1847openalex-snapshot
Gut microbiome influences incidence and outcomes of breast cancer by regulating levels and activity of steroid hormones in women
inferred← citeshttps://doi.org/10.1002/cnr2.1892openalex-snapshot
Unraveling the intricate relationship: Influence of microbiome on the host immune system in carcinogenesis
inferred← citeshttps://doi.org/10.1002/cnr2.70005openalex-snapshot
Elucidating the Intricate Roles of Gut and Breast Microbiomes in Breast Cancer Metastasis to the Bone
inferred← citeshttps://doi.org/10.1002/cnr2.70029openalex-snapshot
The Role of Microbiome and Probiotics in Chemo‐Radiotherapy‐Induced Diarrhea: A Narrative Review of the Current Evidence
inferred← citeshttps://doi.org/10.1002/cnr2.70585openalex-snapshot
Gut Microbiota: A Potential Role in Modulating Carcinogenesis and Response to Anti‐Cancer Therapies
inferred← citeshttps://doi.org/10.1002/cnx2.70037openalex-snapshot
Microbiome and Tumor Microenvironment Interactions: Advances From Ecological Niches to Precision Oncology
inferred← citeshttps://doi.org/10.1002/cph4.70231openalex-snapshot
From Mouth to Brain: Exploring Oral Microbiome Alterations and Metabolomic Pathways in Glioma Pathophysiology
inferred← citeshttps://doi.org/10.1002/cph4.70265openalex-snapshot
Microbiome–Tumor–Host Interactions in Cancer Therapy: From Chemoresistance Mechanisms to Engineered Living Medicines
inferred← citeshttps://doi.org/10.1002/cpt.1437openalex-snapshot
Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response?
inferred← citeshttps://doi.org/10.1002/cpt.1677openalex-snapshot
The Future of Microbiome‐Based Therapeutics in Clinical Applications
inferred← citeshttps://doi.org/10.1002/ctd2.70001openalex-snapshot
Challenges and advances of immune checkpoint therapy
inferred← citeshttps://doi.org/10.1002/cti2.1111openalex-snapshot
Pre‐existing heterologous T‐cell immunity and neoantigen immunogenicity
inferred← citeshttps://doi.org/10.1002/cti2.70115openalex-snapshot
Peripheral immune dynamics during treatment predict prognosis in HCC receiving TACE plus ICIs and anti‐ VEGF / TKIs
inferred← citeshttps://doi.org/10.1002/ctm2.1508openalex-snapshot
Microbiota: A key factor affecting and regulating the efficacy of immunotherapy
inferred← citeshttps://doi.org/10.1002/ctm2.70579openalex-snapshot
Baseline multi‐omics signatures could predict therapeutic response to neoadjuvant anti‐PD‐1 immunochemotherapy in non‐small‐cell lung cancer
inferred← citeshttps://doi.org/10.1002/ctm2.70723openalex-snapshot
Artificial intelligence and oral microbiome: Reshaping the diagnostic and therapeutic paradigm of OSCC
inferred← citeshttps://doi.org/10.1002/ctm2.948openalex-snapshot
Live bacterial supplementation for improving treatment response in metastatic renal cell carcinoma
inferred← citeshttps://doi.org/10.1002/efd2.70171openalex-snapshot
The Supporting Role of Natural Products as Effective Adjuvants in Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/eji.201948322openalex-snapshot
The microbiota and immune‐mediated diseases: Opportunities for therapeutic intervention
inferred← citeshttps://doi.org/10.1002/eji.201948354openalex-snapshot
Gut microbiota alterations affect glioma growth and innate immune cells involved in tumor immunosurveillance in mice
inferred← citeshttps://doi.org/10.1002/eji.202049158openalex-snapshot
Tumor cell‐intrinsic RIG‐I signaling governs synergistic effects of immunogenic cancer therapies and checkpoint inhibitors in mice
inferred← citeshttps://doi.org/10.1002/eji.202250183openalex-snapshot
Training the microbiota to increase immune checkpoint blockade and to reduce toxicity
inferred← citeshttps://doi.org/10.1002/eji.202250337openalex-snapshot
Single‐cell phenotyping of bacteria combined with deep sequencing for improved contextualization of microbiome analyses
inferred← citeshttps://doi.org/10.1002/eji.202451022openalex-snapshot
Gut bacteria, host immunity, and colorectal cancer: From pathogenesis to therapy
inferred← citeshttps://doi.org/10.1002/eji.202451484openalex-snapshot
Investigating Polyreactivity of CD4 + T Cells to the Intestinal Microbiota
inferred← citeshttps://doi.org/10.1002/eji.202451528openalex-snapshot
Updating the Discontinuity Theory to the Extended Immunity: The Symmunobiome Concept
inferred← citeshttps://doi.org/10.1002/exp.20220001openalex-snapshot
Recent progress of metal‐based nanomaterials with anti‐tumor biological effects for enhanced cancer therapy
inferred← citeshttps://doi.org/10.1002/fft2.40openalex-snapshot
Modulation of the host microbiome by black raspberries or their components and the therapeutic implications in cancer
inferred← citeshttps://doi.org/10.1002/fsn3.4637openalex-snapshot
Transcriptomic and Metabolomic Insights Into the Prebiotic Potential of Camellia Seed Oil for Enhancing Akkermansia muciniphila Proliferation In Vitro
inferred← citeshttps://doi.org/10.1002/gch2.202100051openalex-snapshot
Potential Utility of Induced Translocation of Engineered Bacteria as a Therapeutic Agent for Mounting a Personalized Neoantigen‐Based Tumor Immune Response
inferred← citeshttps://doi.org/10.1002/gtm2.70023openalex-snapshot
Standardized Research Methodology for Akkermansia muciniphila : Multi‐Omics Integration, Functional Evaluation, and Clinical Translation Pathways
inferred← citeshttps://doi.org/10.1002/hed.26619openalex-snapshot
Chemoradiation therapy changes oral microbiome and metabolomic profiles in patients with oral cavity cancer and oropharyngeal cancer
inferred← citeshttps://doi.org/10.1002/hed.27917openalex-snapshot
Lachnoclostridium intestinal flora is associated with immunotherapy efficacy in nasopharyngeal carcinoma
inferred← citeshttps://doi.org/10.1002/hed.70392openalex-snapshot
Antibiotic Use and Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma
inferred← citeshttps://doi.org/10.1002/hep4.1331openalex-snapshot
Role of the Gut–Liver Axis in Liver Inflammation, Fibrosis, and Cancer: A Special Focus on the Gut Microbiota Relationship
inferred← citeshttps://doi.org/10.1002/hep4.1905openalex-snapshot
Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1002/hon.3301openalex-snapshot
Role of gut microbiome in the outcome of lymphoma patients treated with checkpoint inhibitors—The MicroLinf Study
inferred← citeshttps://doi.org/10.1002/iid3.1263openalex-snapshot
Potential mechanisms and targeting strategies of the gut microbiota in antitumor immunity and immunotherapy
inferred← citeshttps://doi.org/10.1002/iid3.70145openalex-snapshot
A Perspective on Lung Cancer and Lung Microbiome: Insight on Immunity
inferred← citeshttps://doi.org/10.1002/iid3.70196openalex-snapshot
Immune Checkpoint Molecules: A Review on Pathways and Immunotherapy Implications
inferred← citeshttps://doi.org/10.1002/iid3.70435openalex-snapshot
Probiotics Cancer Interaction, Prevention, and Therapy
inferred← citeshttps://doi.org/10.1002/ijc.32003openalex-snapshot
Fecal microbiota transplantation in cancer management: Current status and perspectives
inferred← citeshttps://doi.org/10.1002/ijc.32343openalex-snapshot
Beyond the tumour microenvironment
inferred← citeshttps://doi.org/10.1002/ijc.33557openalex-snapshot
Clinical impact of probiotics on the efficacy of anti‐PD ‐1 monotherapy in patients with nonsmall cell lung cancer: A multicenter retrospective survival analysis study with inverse probability of treatment weighting
inferred← citeshttps://doi.org/10.1002/ijc.34033openalex-snapshot
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab
inferred← citeshttps://doi.org/10.1002/ijc.34118openalex-snapshot
Dynamic microbiome and metabolome analyses reveal the interaction between gut microbiota and anti‐PD ‐1 based immunotherapy in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/ijc.34464openalex-snapshot
How to overcome resistance to immune checkpoint inhibitors in colorectal cancer: From mechanisms to translation
inferred← citeshttps://doi.org/10.1002/ijc.34842openalex-snapshot
Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non‐small‐cell lung cancer
inferred← citeshttps://doi.org/10.1002/ijc.35181openalex-snapshot
New players in the landscape of renal cell carcinoma bone metastasis and therapeutic opportunities
inferred← citeshttps://doi.org/10.1002/ijc.35298openalex-snapshot
Modeling cancer–microbiome interactions in vitro: A guide to co‐culture platforms
inferred← citeshttps://doi.org/10.1002/imm3.70040openalex-snapshot
bacNeo: A Computational Toolkit for Identifying Bacteria‐Derived Neoantigens in Human Cancers
inferred← citeshttps://doi.org/10.1002/imo2.70081openalex-snapshot
Microbiome‐urothelium crosstalk in bladder cancer: From dysbiosis to clinical translation
inferred← citeshttps://doi.org/10.1002/imo2.70126openalex-snapshot
Microbiome—pancreatic cancer crosstalk: From tumor biology to therapeutic intervention
inferred← citeshttps://doi.org/10.1002/imt2.156openalex-snapshot
Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies
inferred← citeshttps://doi.org/10.1002/imt2.70066openalex-snapshot
Akkermansia muciniphila‐derived hypoacylated rough‐type lipopolysaccharides alleviate diet‐induced obesity via activation of TLR4−IL‐23−IL‐22 immune axis
inferred← citeshttps://doi.org/10.1002/imt2.70070openalex-snapshot
The microbiome in cancer
inferred← citeshttps://doi.org/10.1002/imt2.70081openalex-snapshot
Characterizing the microbiome of “sterile” organs in experimental mice and evidence of translocation of bacteria from the gut to other internal organs
inferred← citeshttps://doi.org/10.1002/inmd.70155openalex-snapshot
Targeting the intratumoral microbiota to overcome cancer immunotherapy resistance
inferred← citeshttps://doi.org/10.1002/iub.2558openalex-snapshot
PD ‐1/ PD‐L1 blockade: Prospectives for immunotherapy in cancer and autoimmunity
inferred← citeshttps://doi.org/10.1002/jbt.23438openalex-snapshot
Anti‐PD‐1 therapy for advanced colorectal cancer based on intestinal microecology
inferred← citeshttps://doi.org/10.1002/jbt.70557openalex-snapshot
Enhancing Anticancer Treatment Efficacy With Lycopene: A Comprehensive Review of Clinical and Preclinical Evidence
inferred← citeshttps://doi.org/10.1002/jcc5.70090openalex-snapshot
Protocol for the Therapy Personalisation Using Multiomic Analyses in Inflammatory Bowel Disease (THAMES‐IBD) Study
inferred← citeshttps://doi.org/10.1002/jcla.23318openalex-snapshot
The association between gut butyrate‐producing bacteria and non‐small‐cell lung cancer
inferred← citeshttps://doi.org/10.1002/jcp.28333openalex-snapshot
Is it true that gut microbiota is considered as panacea in cancer therapy?
inferred← citeshttps://doi.org/10.1002/jcp.29359openalex-snapshot
Gut microbiome and cancer immunotherapy
inferred← citeshttps://doi.org/10.1002/jcp.30272openalex-snapshot
Gold digging: Searching for gut microbiota that enhances antitumor immunity
inferred← citeshttps://doi.org/10.1002/jcp.30917openalex-snapshot
Gut microbiome in tumorigenesis and therapy of colorectal cancer
inferred← citeshttps://doi.org/10.1002/jev2.12328openalex-snapshot
Extracellular vesicles derived from Akkermansia muciniphila promote placentation and mitigate preeclampsia in a mouse model
inferred← citeshttps://doi.org/10.1002/jgh3.70346openalex-snapshot
Effect of Butyrate‐Producing Enterobacteria and Proton Pump Inhibitors on Advanced Hepatocellular Carcinoma Treatment With Durvalumab and Tremelimumab
inferred← citeshttps://doi.org/10.1002/jgh3.70409openalex-snapshot
Gut Microbiota and Extraintestinal Cancers: Mechanistic Insights and Microbiome‐Targeted Interventions
inferred← citeshttps://doi.org/10.1002/jgm.3639openalex-snapshot
Akkermansia muciniphila might improve anti‐PD‐1 therapy against HCC by changing host bile acid metabolism
inferred← citeshttps://doi.org/10.1002/jhbp.944openalex-snapshot
Advances in immunotherapy for pancreatic ductal adenocarcinoma
inferred← citeshttps://doi.org/10.1002/jia2.25300openalex-snapshot
The genital tract and rectal microbiomes: their role in HIV susceptibility and prevention in women
inferred← citeshttps://doi.org/10.1002/jlb.3ri0620-405rropenalex-snapshot
Age-related changes in intestinal immunity and the microbiome
inferred← citeshttps://doi.org/10.1002/jlb.5bt0420-585rropenalex-snapshot
Breakthrough concepts in immune-oncology: Cancer vaccines at the bedside
inferred← citeshttps://doi.org/10.1002/jlb.5ri1017-401rropenalex-snapshot
Obesity as an immune-modifying factor in cancer immunotherapy
inferred← citeshttps://doi.org/10.1002/jso.26339openalex-snapshot
Immune checkpoint blockade in renal cell carcinoma
inferred← citeshttps://doi.org/10.1002/jso.27626openalex-snapshot
Organoids as an in vitro model to study human tumors and bacteria
inferred← citeshttps://doi.org/10.1002/lio2.235openalex-snapshot
The evolving role of immuno‐oncology for the treatment of head and neck cancer
inferred← citeshttps://doi.org/10.1002/mbo3.70431openalex-snapshot
The Microbiome in Glioblastoma: Mechanisms, Tumor–Immune Interactions, and Translational Perspectives
inferred← citeshttps://doi.org/10.1002/mco2.105openalex-snapshot
Therapeutic advances in non‐small cell lung cancer: Focus on clinical development of targeted therapy and immunotherapy
inferred← citeshttps://doi.org/10.1002/mco2.221openalex-snapshot
Human microbiomes in cancer development and therapy
inferred← citeshttps://doi.org/10.1002/mco2.387openalex-snapshot
Progresses in biomarkers for cancer immunotherapy
inferred← citeshttps://doi.org/10.1002/mco2.417openalex-snapshot
Microbiota in cancer: molecular mechanisms and therapeutic interventions
inferred← citeshttps://doi.org/10.1002/mco2.70018openalex-snapshot
Influence of gut and lung dysbiosis on lung cancer progression and their modulation as promising therapeutic targets: a comprehensive review
inferred← citeshttps://doi.org/10.1002/mco2.70085openalex-snapshot
Antimicrobial peptide DP7 alleviates dextran sulfate sodium (DSS)‐induced colitis via modifying gut microbiota and regulating intestinal barrier function
inferred← citeshttps://doi.org/10.1002/mco2.70162openalex-snapshot
Pancreatic Cancer: Pathogenesis and Clinical Studies
inferred← citeshttps://doi.org/10.1002/mco2.70168openalex-snapshot
Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
inferred← citeshttps://doi.org/10.1002/mco2.70249openalex-snapshot
The Interplay of Cross‐Organ Immune Regulation in Inflammation and Cancer
inferred← citeshttps://doi.org/10.1002/mco2.70274openalex-snapshot
Improvement of the Anticancer Efficacy of PD‐1/PD‐L1 Blockade: Advances in Molecular Mechanisms and Therapeutic Strategies
showing the first 200 of 5601
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.